Transistion from manual to femto keratoplasty

Article

A commitment to predictability and safety

The introduction of femtosecond laser technology in the ophthalmologic practice has given rise to significant advances in a great variety of corneal surgical procedures, especially in terms of predictability and safety. This technology, based on the use of a solid state laser (Nd:Glass) beam of a wavelength of 1040–1060 nm, is able to induce a photodisruption of the corneal tissue at a specific plane without thermal or shockwave damage to the surrounding tissue, and with a extremely high level of precision. Specifically, femtosecond lasers form a series of microbubbles (3–12 µm) of carbon dioxide and water vapour due to the photodisruption induced at the programmed depth. These microbubbles interconnect generating a dissection plane. This capability of femtosecond laser technology of precisely programming and generating different types of corneal tissue dissections makes it a valuable tool for keratoplasty.

A valuable tool

Another significant advantage of femto keratoplasty is the possibility of customizing the corneal trephination according to an established pattern. As presented at Femto Keratoplasty Forum 2012 by Dr Thomas Neuhann, it is highly recommended to use dissections with an internal diameter smaller than the external and slanted inwards to promote good self healing.7 This can easily be achieved with the zigzag, tongue in groove ('barrel'), and 'square-zag' shapes.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.